Silke Oßwald

phone +49 30 94793 104

Press Releases

Entry from: 27.02.2019  
Category: News, Press Releases

Pharmacological master key discovered to calm nerve activity

A research team from Berlin and Kiel discovers new pharmacological mechanism in potassium channels. With this, excessive electrical activity in nerve or muscle cells can be contained. The results have been published in the renowned scientific journal Science. [more]

Entry from: 18.02.2019  
Category: News, Press Releases

"Salt Prince" CC1: Newly discovered protein has important function in plants - and could also be important for Alzheimer's research

An international team led by scientists Arndt Wallmann from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Christopher Kesten from the University of Melbourne, now ETH Zurich, describe in a recent study published in the scientific journal (...)[more]

Entry from: 08.01.2019  
Category: News, Press Releases

Volker Haucke receives Feldberg Prize

Prof. Volker Haucke, Director at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) receives the Feldberg Prize 2020, which is awarded annually by the Feldberg Foundation for anglo-german scientific exchange. The aim is to promote scientific (...)[more]

Entry from: 28.11.2018  
Category: Press Releases, News

More sensitive MRI diagnostics thanks to innovative “elastic” contrast media

Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have found a new method for obtaining high-quality images in magnetic resonance imaging (MRI), that requires less contrast medium compared to current methods. It is made possible (...)[more]

Entry from: 26.11.2018  
Category: Press Releases, News

Researchers identify potential active drug substance for rare disease

Cavernous malformations in the brain: Indirubin-3-monoxime may be able to relieve symptoms In a wide-ranging study involving zebrafish, a consortium of the Hannover Medical School (MHH) and the University of Potsdam (UP) led by Professor Salim Seyfried has (...)[more]

Entry from: 19.11.2018  
Category: Press Releases, News

Wissenschaftspreis für Leibniz-Molekularbiologen Thomas J. Jentsch und Entwicklungsforscher - Stifterverband und Leibniz-Gemeinschaft würdigen gesellschaftsrelevante Forschung

Der Wissenschaftspreis des Stifterverbandes „Gesellschaft braucht Wissenschaft“ geht in diesem Jahr an Thomas J. Jentsch vom Leibniz-Forschungsinstitut für Molekulare Pharmakologie sowie an Macartan Humphreys vom Wissenschaftszentrum Berlin für Sozialforschung, (...)[more]

Entry from: 16.11.2018  
Category: Press Releases, News

A new Research Training Group focuses on Peptides, the “little brothers and sisters” of proteins

TU Berlin is to act as host university of the new “Bioactive Peptides – Innovative Aspects of Synthesis and Biosynthesis” Research Training Group (RTG2473/1). The German Research Foundation (DFG) approved the funding of this new Research Training Group on 9 (...)[more]

Entry from: 25.09.2018  
Category: Press Releases, News

EU-OPENSCREEN als europäische Forschungsinfrastruktur ausgezeichnet - weniger Hürden bei der Suche nach neuen Wirkstoffen

Die Europäische Kommission verleiht dem Konsortium EU-OPENSCREEN den begehrten Status European Research Infrastructure Consortium (ERIC). Das Konsortium bündelt die Infrastruktur von 20 Forschungsinstituten aus bislang sieben europäischen Ländern. Am 25. (...)[more]

Entry from: 28.08.2018  
Category: News, Press Releases

Presynapses come in a packet – Berlin Scientists Identify the Components and Architecture of Neuronal Contact Sites

Synapses are the interfaces for information exchange between neurons. Teams of scientists working with Professor Dr. Volker Haucke, Director at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Professor at the Freie Universität Berlin, and (...)[more]

Entry from: 08.08.2018  
Category: News, Press Releases

A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has (...)[more]


Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)

Like many sites, we use cookies to optimize the user's browsing experience. Data Protection OK